首页> 外文期刊>Neuro-Oncology >Rapid, label-free detection of diffuse glioma recurrence using intraoperative stimulated Raman histology and deep neural networks
【24h】

Rapid, label-free detection of diffuse glioma recurrence using intraoperative stimulated Raman histology and deep neural networks

机译:使用术中刺激的拉曼组织学和深神经网络无快速,无标记的粘结胶质瘤复发检测

获取原文
获取原文并翻译 | 示例
       

摘要

Background. Detection of glioma recurrence remains a challenge in modern neuro-oncology. Noninvasive radiographic imaging is unable to definitively differentiate true recurrence versus pseudoprogression. Even in biopsied tissue, it can be challenging to differentiate recurrent tumor and treatment effect. We hypothesized that intraoperative stimulated Raman histology (SRH) and deep neural networks can be used to improve the intraoperative detection of glioma recurrence.Methods. We used fiber laser-based SRH, a label-free, nonconsumptive, high-resolution microscopy method (60 sec per 1 x 1 mm(2)) to image a cohort of patients (n = 35) with suspected recurrent gliomas who underwent biopsy or resection. The SRH images were then used to train a convolutional neural network (CNN) and develop an inference algorithm to detect viable recurrent glioma. Following network training, the performance of the CNN was tested for diagnostic accuracy in a retrospective cohort (n = 48).Results. Using patch-level CNN predictions, the inference algorithm returns a single Bernoulli distribution for the probability of tumor recurrence for each surgical specimen or patient. The external SRH validation dataset consisted of 48 patients (recurrent, 30; pseudoprogression, 18), and we achieved a diagnostic accuracy of 95.8%.Conclusion. SRH with CNN-based diagnosis can be used to improve the intraoperative detection of glioma recurrence in near-real time. Our results provide insight into how optical imaging and computer vision can be combined to augment conventional diagnostic methods and improve the quality of specimen sampling at glioma recurrence.
机译:背景。胶质瘤复发的检测仍然是现代神经肿瘤的挑战。非侵入性放射线影像成像无法明确地区分真正的复发与假冒竞争。即使在活检组织中,也可能具有挑战性,以区分复发性肿瘤和治疗效果。我们假设术中刺激的拉曼组织学(SRH)和深神经网络可用于改善胶质瘤复发的术中检测。方法。我们使用基于光纤激光的SRH,一种无标记,非承认,高分辨率的显微镜方法(<60秒,每1×1mm(2)),用疑似复发性Gliomas进行患者(n = 35)的群体(n = 35)活检或切除。然后使用SRH图像来训练卷积神经网络(CNN)并开发推理算法以检测可行的复发性胶质瘤。在网络训练之后,在回顾性队列(n = 48)中测试CNN的性能以进行诊断准确性。结果。使用补丁级CNN预测,推理算法返回每个手术样本或患者的肿瘤复发概率的单个Bernoulli分布。外部SRH验证数据集由48名患者(复发,30;假冒竞争,18)组成,我们达到了95.8%的诊断准确性。结论。 SRH基于CNN的诊断可用于改善近期胶质瘤复发的术中检测。我们的结果提供了深入了解光学成像和计算机视觉如何组合以增强常规诊断方法,提高胶质瘤复发的样本采样质量。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号